補助人工心臓の世界市場の機会と2032年までの戦略Including：1) 製品別製品別：左心室補助装置（LVADs）、右心室補助装置（RVADs）、両心室補助装置（BIVADs）2）タイプ別：拍動流、連続流3）デザイン別：連続流、拍動流、連続流拍動流；連続流3) デザイン別：デザイン別：経皮的心室補助装置；植え込み型心室補助装置4）用途別移植までの橋渡し（BTT）療法；目的地療法；回復までの橋渡し（BTR）療法；候補地までの橋渡し（BTC）療法5) エンドユーザー別：病院；外来手術センター；心臓病センターカバーする：アビオメッド; アボット・ラボラトリーズ; メドトロニック; リバノバPLC; テルモコーポレーション

Ventricular Assist Device Global Market Opportunities And Strategies To 2032Including: 1) By Product: Left Ventricular Assist Devices (LVADs); Right Ventricular Assist Devices (RVADs); Biventricular Assist Devices (BIVADs)2) By Type: Pulsatile Flow; Continuous Flow3) By Design: Transcutaneous Ventricular Assist Devices; Implantable Ventricular Assist Devices4) By Application: Bridge-To-Transplant (BTT) Therapy; Destination Therapy; Bridge-To-Recovery (BTR) Therapy; Bridge-To-Candidacy (BTC) Therapy5) By End Users: Hospital; Ambulatory Surgical Centres; Cardiology CentresCovering: Abiomed; Abbott Laboratories; Medtronic; LivaNova PLC; Terumo Corporation

この調査レポートは、心室補助装置の世界市場のビジネスチャンスと2032年までの戦略を掲載し、戦略担当者、マーケティング担当者、上級管理職がCOVID-19の閉鎖から抜け出した世界の心室補助装置市場を評価するの... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
The Business Research Company　(TBRC) ザ・ビジネスリサーチカンパニー	2023年2月20日	US$5,000 シングルユーザライセンスライセンス・価格情報・注文方法はこちら	328	英語

サマリー

この調査レポートは、心室補助装置の世界市場のビジネスチャンスと2032年までの戦略を掲載し、戦略担当者、マーケティング担当者、上級管理職がCOVID-19の閉鎖から抜け出した世界の心室補助装置市場を評価するのに必要な重要情報を提供しています。

購入の理由
- 12地域をカバーするこの市場に関する最も包括的なレポートにより、真にグローバルな視点を得ることができます。
- 市場がコロナウイルスによってどのような影響を受けているか、またウイルスの影響が和らぐにつれて市場がどのように浮上し、成長しそうかを理解する。
- 現地のデータと分析に基づき、地域別および国別の戦略を策定します。
- 投資の対象となる成長セグメントを特定する。
- 予測データと市場を形成するドライバーとトレンドを活用し、競合他社を凌駕する。
- 最新の市場調査結果に基づいて顧客を理解する。
- 主要な競合他社とのパフォーマンスの比較
- 主要データセット間の関係を活用し、優れた戦略を立てる。
- 信頼性の高い高品質なデータと分析により、社内外のプレゼンテーションをサポートするのに適しています。
- レポートは最新データに更新され、ご注文から3～5営業日以内にお届けします。

説明
補助人工心臓の最大市場および急成長市場はどこか？経済全体、人口動態、他の類似市場との関連は？今後の市場を形成する勢力は何か？この調査レポートは、補助人工心臓市場の世界市場に関するすべての質問とその他の多くの質問に回答しています。
当レポートでは、市場の特徴、規模と成長、セグメンテーション、地域別および国別内訳、競合情勢、市場シェア、市場の動向と戦略について取り上げています。市場の歴史をたどり、地域別の市場成長を予測しています。同市場を補助人工心臓市場全体の中で位置づけ、他市場との比較も行っています。

本レポートは以下の章をカバーしています。
- 序論と市場の特徴
補助人工心臓市場に関する定義や解説、市場の対象となるセグメントを簡単に紹介しています。
- 主要動向
補助人工心臓の世界市場を形成している主要トレンドをハイライトしています。また、同市場における今後の展開についても取り上げます。
- 世界の市場規模と成長
世界の過去（2017年～2022年）および予測（2022年～2027年）、（2027年～2032年）市場価値、過去および予測期間における市場の成長を支え、制御する推進要因と抑制要因について解説します。
- 地域別分析
地域別の過去（2017-2022年）および予測（2022-2027年）、（2027-2032年）市場価値と成長率、市場シェア比較。
- 市場セグメンテーション
市場における製品別、タイプ別、デザイン別、用途別、エンドユーザー別の市場価値（2017-2032年）と各セグメントの分析を収録。
- 地域別市場規模と成長
地域別の市場規模（2022年）、過去（2017年～2022年）と予測（2022年～2027年）、（2027年～2032年）の市場価値、地域内の国々の成長と市場シェア比較。本レポートには、アジア太平洋、西欧、東欧、北米、南米、中東、アフリカの全地域と各地域内の主要国に関する情報が含まれています。
- 競争環境
市場の競争状況、推定市場占有率、主要企業の会社プロファイルの詳細を掲載しています。
- 主要なM&A
本レポートでカバーしている市場における最近のM&Aに関する情報を掲載しています。本セクションでは、近年の市場を形成したM&Aに関する主要な財務情報を掲載しています。
- 市場機会と戦略
調査結果に基づく市場機会と戦略について、国やセグメントごとの成長機会や、それらの市場で取るべき戦略に関する情報を交えて記述しています。
- 結論と提言
製品/サービスの提供地域拡大、マーケティング戦略、ターゲットグループなど、補助人工心臓プロバイダーへの提言が含まれています。
- 付録
このセクションには、本レポートで使用されているNAICSコード、略語、通貨コードの詳細が含まれています。

対象範囲
対象市場
1) 製品別左心室補助装置（LVADs）；右心室補助装置（RVADs）；両心室補助装置（BIVADs）。
2) タイプ別：拍動流；連続流
3) デザイン別経皮的補助人工心臓；植込み型補助人工心臓
4) 用途別移植橋渡し（BTT）療法；目的地療法；回復橋渡し（BTR）療法；候補地橋渡し（BTC）療法
5) エンドユーザー別病院；外来手術センター；心臓病センター

言及された企業アビオメッド；アボット・ラボラトリーズ；メドトロニック；リバノバPLC；テルモ株式会社

国中国; オーストラリア; インド; インドネシア; 日本; 韓国; 米国; ブラジル; フランス; ドイツ; 英国; ロシア

地域アジア太平洋; 西ヨーロッパ; 東ヨーロッパ; 北アメリカ; 南アメリカ; 中東; アフリカ

時系列：過去5年、予測10年

データ関連市場に対する市場規模および成長率、GDP比率、一人当たり支出、補助人工心臓の指標比較。

データ区分: 国別および地域別の過去データと予測データ; 競合企業の市場シェア; 市場セグメント。

ソーシングと参照：レポート中のデータおよび分析はエンドノートを使用しています。

当レポートでは、補助人工心臓市場について説明し、歴史的期間と呼ばれる2017-2022年と予測期間と呼ばれる2022-2027年をカバーし、さらに2027-2032年の予測も行っています。各地域および各地域内の主要経済圏の市場を評価しています。

補助人工心臓の世界市場規模は、2017年以降年平均成長率（CAGR）9.3％で成長し、2022年には約17億120万ドルに達した。同市場は、2022年の17億120万ドルから2027年には30億310万ドルに12.0%の成長率で拡大すると予測される。その後、2027年から年平均成長率（CAGR）12.0%で成長し、2032年には52億9,580万ドルに達すると予想される。

歴史的期間の成長は、心不全の有病率の増加と臓器移植手術の需要増に起因する。

今後は、目的地治療のニーズの増加、人口の高齢化、医療費の増加、心不全治療に関する意識の高まりが成長の原動力になるだろう。今後の補助人工心臓市場の成長を阻害する要因としては、補助人工心臓に関連する副作用などが挙げられる。

補助人工心臓市場は、製品別に左心室補助人工心臓（LVAD）、右心室補助人工心臓（RVAD）、両心室補助人工心臓（BIVAD）に区分される。左室補助循環装置（LVAD）市場は、2022年の製品別補助循環装置市場全体の84.9%を占める最大セグメントであった。今後、両心室補助装置（BIVADs）市場は、製品別にセグメント化された補助人工心臓市場において、2022～2027年のCAGR13.0％で最も急成長するセグメントとなる見込みである。

補助人工心臓市場は、タイプ別に脈動流と連続流に区分される。連続流市場は、2022年の補助人工心臓市場セグメント別タイプで全体の90.0%を占める最大セグメントであった。今後、補助人工心臓市場のタイプ別セグメントでは、拍動流市場が2022～2027年のCAGR13.1％で最も急成長する見込みである。

補助人工心臓市場は、デザイン別に経皮的補助人工心臓と植え込み型補助人工心臓に区分される。植え込み型補助人工心臓市場は、2022年に全体の75.0％を占めたデザイン別補助人工心臓市場の最大セグメントである。今後、植え込み型補助人工心臓市場は、デザイン別にセグメント化された補助人工心臓市場において、2022～2027年のCAGR 12.5％で最も急成長するセグメントとなる見込みである。

補助人工心臓市場は、用途別にBTT（bridge-to-transplant）療法、目的地療法、BTR（bridge-to-recovery）療法、BTC（bridge-to-candidacy）療法に区分される。2022年の補助人工心臓市場の用途別セグメントでは、目的地治療市場が全体の45.2％を占める最大セグメントであった。今後、橋渡し移植（BTT）療法市場は、用途別にセグメント化された補助人工心臓市場において最も急速に成長するセグメントであり、2022～2027年のCAGRは12.6%となる見込みである。

補助人工心臓市場は、エンドユーザー別に病院、外来手術センター、心臓病センターに区分される。2022年の補助人工心臓市場のエンドユーザー別セグメントでは、病院市場が全体の69.9%を占める最大セグメントであった。今後、病院市場はエンドユーザー別に区分された補助人工心臓市場において、2022～2027年の年平均成長率（CAGR）12.3％で最も急成長するセグメントとなる見込みである。

補助人工心臓市場において最大の地域は北米で、2022年には全体の37.3％を占めた。次いで西ヨーロッパ、その他の地域と続く。今後、補助人工心臓市場で最も急速に成長する地域はアジア太平洋地域と中東で、それぞれCAGR 23.6%と5.2%で成長する。これに続くのは南米と東欧で、それぞれCAGR 5.2％と2.8％の成長が見込まれる。

補助人工心臓の世界市場は、少数の大企業に集中している。2021年の市場全体の53.22%は上位10社で占められている。最近の技術革新が各社の市場プレゼンス強化に貢献した。アビオメッドが市場シェア19.62%で最大、次いでアボット・ラボラトリーズが14.76%、メドトロニックが7.85%、LivaNova PLCが3.32%、テルモが2.85%、ベルリンハートGmbHが1.46%、Cirtecが1.37%、Jarvik Heart Inc.が0.86%、SynCardia Systems, LLC.が0.80%、Calon Cardio-Technology Ltd.が0.33%となっている。

補助人工心臓市場を製品別にセグメント化すると、2027年までに世界の年間売上高が11億650万ドルに達する左室補助人工心臓（LVAD）セグメントに最大のビジネスチャンスが生まれる。補助人工心臓市場をタイプ別にセグメント化すると、2027年までに年間11億5780万ドルの世界売上高を獲得する連続フロー・セグメントに最大のビジネスチャンスが生まれる。デザイン別セグメントでは、植え込み型補助人工心臓が上位を占め、2027年までに世界の年間売上高は10億2670万ドルに達するだろう。用途別では、2027年までに世界の年間売上高が5億8,700万ドルに拡大する目的地治療が上位を占めるだろう。エンドユーザー別では、2027年までに世界の年間売上高が9億3,100万ドルに達する病院が上位を占めるだろう。補助人工心臓の市場規模は、米国が10億5,310万ドルで最も拡大する。

補助人工心臓市場の市場トレンドに基づく戦略には、補助人工心臓の有効寿命延長への注力、補助人工心臓の小型化、先進ポンプ技術、補助人工心臓の安全性と有効性への注目の高まり、補助人工心臓の副作用軽減への注力、経皮的に挿入される補助人工心臓などがある。

補助人工心臓市場で各社が採用している戦略には、規制当局の承認取得による事業運営の強化、革新的ソリューションの提供への注力、救命技術を重症患者にとってより身近なものにすることへの注力などがある。

ビジネスリサーチカンパニーは、この機会を活用するために、補助人工心臓メーカー各社に、高度なポンプ技術への注力、経皮挿入型補助人工心臓への投資、補助人工心臓の安全性と有効性への注力、新興市場での事業拡大、先進国市場への継続的な注力、パートナーシップとコラボレーションへの注力、競争力のある価格での提供、展示会やイベントへの参加、高齢化社会への注力、急成長するエンドユーザーへの継続的なアプローチを推奨している。

ページTOPに戻る

1. Executive Summary
2. Table Of Contents
3. List Of Figures
4. List Of Tables
5. Report Structure
6. Introduction and Market Characteristics
6.1. General Market Definition
6.2. Summary
6.3. Ventricular Assist Device Market Definition And Segmentations
6.4. Market Segmentation By Product
6.4.1. Left Ventricular Assist Devices (LVADs)
6.4.2. Right Ventricular Assist Devices (RVADs)
6.4.3. Biventricular Assist Devices (BIVADs)
6.5. Market Segmentation By Type
6.5.1. Pulsatile Flow
6.5.2. Continuous Flow
6.6. Market Segmentation By Design
6.6.1. Transcutaneous Ventricular Assist Devices
6.6.2. Implantable Ventricular Assist Devices
6.7. Market Segmentation By Application
6.7.1. Bridge-To-Transplant (BTT) Therapy
6.7.2. Destination Therapy
6.7.3. Bridge-To-Recovery (BTR) Therapy
6.7.4. Bridge-To-Candidacy (BTC) Therapy
6.8. Market Segmentation By End User
6.8.1. Hospitals
6.8.2. Ambulatory Surgical Centers
6.8.3. Cardiology Centers
7. Major Market Trends
7.1. Focus On Lengthening Effective Life Of VADs
7.2. Miniaturization Of VADs
7.3. Advanced Pump Technologies
7.4. Increased Focus On VAD Safety And Effectiveness
7.5. Reduction In Side Effects Of VADs
7.6. Percutaneously Inserted Ventricular Assist Devices
8. Global Market Size and Growth
8.1. Market Size
8.2. Historic Market Growth, 2017 – 2022, Value ($ Million)
8.2.1. Market Drivers 2017 – 2022
8.2.2. Market Restraints 2017 – 2022
8.3. Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
8.3.1. Market Drivers 2022 – 2027
8.3.2. Market Restraints 2022 – 2027
9. Global Ventricular Assist Device Market Segmentation
9.1. Global Ventricular Assist Device Market, Segmentation By Product, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
9.2. Global Ventricular Assist Device Market, Segmentation By Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
9.3. Global Ventricular Assist Device Market, Segmentation By Design, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
9.4. Global Ventricular Assist Device Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
9.5. Global Ventricular Assist Device Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
10. Ventricular Assist Device Market, Regional and Country Analysis
10.1. Global Ventricular Assist Device Market, By Region, Historic and Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
10.2. Global Ventricular Assist Device Market, By Country, Historic and Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11. Asia-Pacific Market
11.1. Summary
11.2. Market Overview
11.2.1. Region Information
11.2.2. Market Information
11.2.3. Background Information
11.2.4. Government Initiatives
11.2.5. Regulations
11.2.6. Regulatory Bodies
11.2.7. Major Associations
11.2.8. Taxes levied
11.2.9. Corporate Tax Structure
11.2.10. Investments
11.2.11. Major Companies
11.3. Asia-Pacific Ventricular Assist Device Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.4. Asia-Pacific Ventricular Assist Device Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.5. Asia-Pacific Ventricular Assist Device Market, Segmentation By Product, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.6. Asia-Pacific Ventricular Assist Device Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.7. Asia-Pacific Ventricular Assist Device Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.8. Asia-Pacific Ventricular Assist Device Market: Country Analysis
11.9. China Market
11.10. Summary
11.11. Market Overview
11.11.1. Country Information
11.11.2. Market Information
11.11.3. Background Information
11.11.4. Government Initiatives
11.11.5. Regulations
11.11.6. Regulatory Bodies
11.11.7. Major Associations
11.11.8. Taxes Levied
11.11.9. Corporate tax structure
11.11.10. Investments
11.11.11. Major Companies
11.12. China Ventricular Assist Device Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.13. China Ventricular Assist Device Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.14. China Ventricular Assist Device Market, Segmentation By Product, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.15. China Ventricular Assist Device Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.16. China Ventricular Assist Device Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.17. India Market
11.18. India Ventricular Assist Device Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.19. India Ventricular Assist Device Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.20. India Ventricular Assist Device Market, Segmentation By Product, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.21. India Ventricular Assist Device Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.22. India Ventricular Assist Device Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.23. Japan Market
11.24. Japan Ventricular Assist Device Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.25. Japan Ventricular Assist Device Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.26. Japan Ventricular Assist Device Market, Segmentation By Product, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.27. Japan Ventricular Assist Device Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.28. Japan Ventricular Assist Device Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.29. Australia Market
11.30. Australia Ventricular Assist Device Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.31. Australia Ventricular Assist Device Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.32. Australia Ventricular Assist Device Market, Segmentation By Product, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.33. Australia Ventricular Assist Device Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.34. Australia Ventricular Assist Device Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.35. Indonesia Market
11.36. Indonesia Ventricular Assist Device Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.37. Indonesia Ventricular Assist Device Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.38. Indonesia Ventricular Assist Device Market, Segmentation By Product, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.39. Indonesia Ventricular Assist Device Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.40. Indonesia Ventricular Assist Device Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.41. South Korea Market
11.42. South Korea Ventricular Assist Device Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.43. South Korea Ventricular Assist Device Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.44. South Korea Ventricular Assist Device Market, Segmentation By Product, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.45. South Korea Ventricular Assist Device Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.46. South Korea Ventricular Assist Device Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12. Western Europe Market
12.1. Summary
12.2. Market Overview
12.2.1. Region Information
12.2.2. Market Information
12.2.3. Background Information
12.2.4. Government Initiatives
12.2.5. Regulations
12.2.6. European Union
12.2.7. Regulatory bodies
12.2.8. Major Associations
12.2.9. Taxes Levied
12.2.10. Corporate Tax Structure
12.2.11. Investments
12.2.12. Major Companies
12.3. Western Europe Ventricular Assist Device Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
12.4. Western Europe Ventricular Assist Device Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
12.5. Western Europe Ventricular Assist Device Market, Segmentation By Product, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.6. Western Europe Ventricular Assist Device Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.7. Western Europe Ventricular Assist Device Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.8. Western Europe Ventricular Assist Device Market: Country Analysis
12.9. UK Market
12.10. UK Ventricular Assist Device Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
12.11. UK Ventricular Assist Device Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
12.12. UK Ventricular Assist Device Market, Segmentation By Product, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.13. UK Ventricular Assist Device Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.14. UK Ventricular Assist Device Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.15. Germany Market
12.16. Germany Ventricular Assist Device Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
12.17. Germany Ventricular Assist Device Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
12.18. Germany Ventricular Assist Device Market, Segmentation By Product, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.19. Germany Ventricular Assist Device Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.20. Germany Ventricular Assist Device Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.21. France Market
12.22. France Ventricular Assist Device Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
12.23. France Ventricular Assist Device Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
12.24. France Ventricular Assist Device Market, Segmentation By Product, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.25. France Ventricular Assist Device Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.26. France Ventricular Assist Device Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13. Eastern Europe Market
13.1. Summary
13.2. Market Overview
13.2.1. Region Information
13.2.2. Market Information
13.2.3. Background Information
13.2.4. Government Initiatives
13.2.5. Regulations
13.2.6. Regulatory bodies
13.2.7. Major Associations
13.2.8. Taxes Levied
13.2.9. Corporate Tax Structure
13.2.10. Major Companies
13.3. Eastern Europe Ventricular Assist Device Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
13.4. Eastern Europe Ventricular Assist Device Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
13.5. Eastern Europe Ventricular Assist Device Market, Segmentation By Product, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.6. Eastern Europe Ventricular Assist Device Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.7. Eastern Europe Ventricular Assist Device Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.8. Eastern Europe Ventricular Assist Device Market: Country Analysis
13.9. Russia Market
13.10. Russia Ventricular Assist Device Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
13.11. Russia Ventricular Assist Device Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
13.12. Russia Ventricular Assist Device Market, Segmentation By Product, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.13. Russia Ventricular Assist Device Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.14. Russia Ventricular Assist Device Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14. North America Market
14.1. Summary
14.2. Market Overview
14.2.1. Region Information
14.2.2. Market Information
14.2.3. Background Information
14.2.4. Government Initiatives
14.2.5. Regulations
14.2.6. Regulatory bodies
14.2.7. Major Associations
14.2.8. Taxes Levied
14.2.9. Corporate Tax Structure
14.2.10. Investments
14.2.11. Major Companies
14.3. North America Ventricular Assist Device Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
14.4. North America Ventricular Assist Device Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
14.5. North America Ventricular Assist Device Market, Segmentation By Product, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.6. North America Ventricular Assist Device Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.7. North America Ventricular Assist Device Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.8. North America Ventricular Assist Device Market: Country Analysis
14.9. USA Market
14.10. Summary
14.11. Market Overview
14.11.1. Country Information
14.11.2. Market Information
14.11.3. Background Information
14.11.4. Government Initiatives
14.11.5. Regulations
14.11.6. Regulatory bodies
14.11.7. Major Associations
14.11.8. Taxes Levied
14.11.9. Corporate Tax Structure
14.11.10. Investments
14.11.11. Major Companies
14.12. USA Ventricular Assist Device Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
14.13. USA Ventricular Assist Device Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
14.14. USA Ventricular Assist Device Market, Segmentation By Product, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.15. USA Ventricular Assist Device Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.16. USA Ventricular Assist Device Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15. South America Market
15.1. Summary
15.2. Market Overview
15.2.1. Region Information
15.2.2. Market Information
15.2.3. Background Information
15.2.4. Government Initiatives
15.2.5. Regulations
15.2.6. Regulatory bodies
15.2.7. Major Associations
15.2.8. Taxes Levied
15.2.9. Corporate Tax Structure
15.2.10. Investments
15.2.11. Major Companies
15.3. South America Ventricular Assist Device Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
15.4. South America Ventricular Assist Device Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
15.5. South America Ventricular Assist Device Market, Segmentation By Product, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.6. South America Ventricular Assist Device Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.7. South America Ventricular Assist Device Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.8. South America Ventricular Assist Device Market: Country Analysis
15.9. Brazil Market
15.10. Brazil Ventricular Assist Device Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
15.11. Brazil Ventricular Assist Device Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
15.12. Brazil Ventricular Assist Device Market, Segmentation By Product, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.13. Brazil Ventricular Assist Device Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.14. Brazil Ventricular Assist Device Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
16. Middle East Market
16.1. Summary
16.2. Market Overview
16.2.1. Region Information
16.2.2. Market Information
16.2.3. Background Information
16.2.4. Government Initiatives
16.2.5. Regulations
16.2.6. Regulatory Bodies
16.2.7. Major Association
16.2.8. Taxes Levied
16.2.9. Corporate Tax Structure
16.2.10. Investments
16.2.11. Major Companies
16.3. Middle East Ventricular Assist Device Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
16.4. Middle East Ventricular Assist Device Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
16.5. Middle East Ventricular Assist Device Market, Segmentation By Product, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
16.6. Middle East Ventricular Assist Device Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
16.7. Middle East Ventricular Assist Device Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
17. Africa Market
17.1. Summary
17.2. Market Overview
17.2.1. Region Information
17.2.2. Market Information
17.2.3. Background Information
17.2.4. Government Initiatives
17.2.5. Regulations
17.2.6. Regulatory Bodies
17.2.7. Major Associations
17.2.8. Taxes Levied
17.2.9. Corporate Tax Structure
17.2.10. Investments
17.2.11. Major Companies
17.3. Africa Ventricular Assist Device Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
17.4. Africa Ventricular Assist Device Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
17.5. Africa Ventricular Assist Device Market, Segmentation By Product, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
17.6. Africa Ventricular Assist Device Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
17.7. Africa Ventricular Assist Device Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
18. Competitive Landscape and Company Profiles
19. Company Profiles
19.1. Abiomed, Inc
19.1.1. Company Overview
19.1.2. Products And Services
19.1.3. Business Strategy
19.1.4. Financial Overview
19.2. Abbott Laboratories
19.2.1. Company Overview
19.2.2. Products And Services
19.2.3. Business Strategy
19.2.4. Financial Overview
19.3. Medtronic plc
19.3.1. Company Overview
19.3.2. Products And Services
19.3.3. Business Strategy
19.3.4. Financial Overview
19.4. LivaNova PLC
19.4.1. Company Overview
19.4.2. Products And Services
19.4.3. Business Strategy
19.4.4. Financial Overview
19.5. Terumo Corporation
19.5.1. Company Overview
19.5.2. Products And Services
19.5.3. Financial Overview
20. Key Mergers and Acquisitions
20.1. Medtronic PLC Acquired Affera, Inc.
20.2. Boston Scientific Corporation Acquired Baylis Medical Company Inc.
20.3. Johnson & Johnson Acquired Abiomed
20.4. Royal Philips Acquired Cardiologs
20.5. ICU Medical Inc. Acquired Smiths Medical
20.6. Picard Medical, Inc. Acquired SynCardia System LLC
21. Opportunities And Strategies
21.1. Global Ventricular Assist Device Market In 2027 – Countries Offering Most New Opportunities
21.2. Global Ventricular Assist Device Market In 2027 – Segments Offering Most New Opportunities
21.3. Global Ventricular Assist Device Market In 2027 – Growth Strategies
21.3.1. Market Trend Based Strategies
21.3.2. Competitor Strategies
22. Ventricular Assist Device Market, Conclusions And Recommendations
22.1. Conclusions
22.2. Recommendations
22.2.1. Product
22.2.2. Place
22.2.3. Price
22.2.4. Promotion
22.2.5. People
23. Appendix
23.1. Market Data Sources
23.2. Research Methodology
23.3. Currencies
23.4. The Business Research Company
23.5. Copyright and Disclaimer

ページTOPに戻る

Table of Contents

Summary

Ventricular Assist Device Global Market Opportunities And Strategies To 2032 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global ventricular assist device market as it emerges from the COVID-19 shut down.

Reasons to Purchase
• Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:
Where is the largest and fastest-growing market for ventricular assist device? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The ventricular assist device market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider ventricular assist device market; and compares it with other markets.

The report covers the following chapters
• Introduction and Market Characteristics
Brief introduction to the segmentations covered in the market, definitions and explanations about the ventricular assist device market.
• Key Trends
Highlights the major trends shaping the global ventricular assist device market. This section also highlights likely future developments in the market.
• Global Market Size and Growth
Global historic (2017-2022) and forecast (2022-2027), and (2027-2032) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
• Regional Analysis
Historic (2017-2022) and forecast (2022-2027), and (2027-2032) market values and growth and market share comparison by region.
• Market Segmentation
Contains the market values (2017-2032) and analysis for each segment by product, by type, by design, by application and by end user in the market.
• Regional Market Size and Growth
Regional market size (2022), historic (2017-2022) and forecast (2022-2027), and (2027-2032) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
• Competitive Landscape
Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
• Key Mergers and Acquisitions
Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
• Market Opportunities And Strategies
Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
• Conclusions And Recommendations
Includes recommendations for ventricular assist device providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
• Appendix
This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Scope
Markets Covered:
1) By Product: Left Ventricular Assist Devices (LVADs); Right Ventricular Assist Devices (RVADs); Biventricular Assist Devices (BIVADs).
2) By Type: Pulsatile Flow; Continuous Flow
3) By Design: Transcutaneous Ventricular Assist Devices; Implantable Ventricular Assist Devices
4) By Application: Bridge-To-Transplant (BTT) Therapy; Destination Therapy; Bridge-To-Recovery (BTR) Therapy; Bridge-To-Candidacy (BTC) Therapy
5) By End Users: Hospital; Ambulatory Surgical Centres; Cardiology Centres

Companies Mentioned: Abiomed; Abbott Laboratories; Medtronic; LivaNova PLC; Terumo Corporation

Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; France; Germany; UK; Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time-series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; ventricular assist device indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

This report describes and explains the ventricular assist device market and covers 2017-2022, termed the historic period, and 2022-2027 termed the forecast period, along with further forecasts for the period 2027-2032. The report evaluates the market across each region and for the major economies within each region.

The global ventricular assist device market reached a value of nearly $1,701.2 million in 2022, having grown at a compound annual growth rate (CAGR) of 9.3% since 2017. The market is expected to grow from $1,701.2 million in 2022 to $3,003.1 million in 2027 at a rate of 12.0%. The market is then expected to grow at a CAGR of 12.0% from 2027 and reach $5,295.8 million in 2032.

Growth in the historic period resulted from an increase in the prevalence of heart failure and a rise in demand for organ transplantation procedures.

Going forward, the increasing need for destination therapy, aging population, increasing healthcare expenditure and a rise in awareness regarding heart failure treatment will drive the growth. Factors that could hinder the growth of the ventricular assist device market in the future include side effects associated with ventricular assist devices.

The ventricular assist device market is segmented by product into left ventricular assist devices (LVADs), right ventricular assist devices (RVADs) and biventricular assist devices (BIVADs). The left ventricular assist devices (LVADs) market was the largest segment of the ventricular assist device market segmented by product accounting for 84.9% of the total in 2022. Going forward, the biventricular assist devices (BIVADs) market is expected to be the fastest growing segment in the ventricular assist device market segmented by product, at a CAGR of 13.0% during 2022-2027.

The ventricular assist device market is segmented by type into pulsatile flow and continuous flow. The continuous flow market was the largest segment of the ventricular assist device market segmented type accounting for 90.0% of the total in 2022. Going forward, the pulsatile flow market is expected to be the fastest growing segment in the ventricular assist device market segmented by type, at a CAGR of 13.1% during 2022-2027.

The ventricular assist device market is segmented by design into transcutaneous ventricular assist devices and implantable ventricular assist devices. The implantable ventricular assist devices market was the largest segment of the ventricular assist device market segmented by design accounting for 75.0% of the total in 2022. Going forward, the implantable ventricular assist devices market is expected to be the fastest growing segment in the ventricular assist device market segmented by design, at a CAGR of 12.5% during 2022-2027.

The ventricular assist device market is segmented by application into bridge-to-transplant (BTT) therapy, destination therapy, bridge-to-recovery (BTR) therapy and bridge-to-candidacy (BTC) therapy. The destination therapy market was the largest segment of the ventricular assist device market segmented by application accounting for 45.2% of the total in 2022. Going forward, the bridge-to-transplant (BTT) therapy market is expected to be the fastest growing segment in the ventricular assist device market segmented by application, at a CAGR of 12.6% during 2022-2027.

The ventricular assist device market is segmented by end user into hospitals, ambulatory surgical centers and cardiology centers. The hospitals market was the largest segment of the ventricular assist device market segmented by end user accounting for 69.9% of the total in 2022. Going forward, the hospitals market is expected to be the fastest growing segment in the ventricular assist device market segmented by end user, at a CAGR of 12.3% during 2022-2027.

North America was the largest region in the ventricular assist device market, accounting for 37.3% of the total in 2022. It was followed by Western Europe, and then the other regions. Going forward, the fastest-growing regions in the ventricular assist device market will be Asia Pacific, and Middle East where growth will be at CAGRs of 23.6% and 5.2% respectively. These will be followed by South America, and Eastern Europe where the markets are expected to grow at CAGRs of 5.2% and 2.8% respectively.

The global ventricular assist device market is concentrated, with a few large players. The top ten competitors in the market made up to 53.22% of the total market in 2021. Technological innovations in the recent past helped the companies to strengthen their market presence. Abiomed was the largest competitor with 19.62% share of the market, followed by Abbott Laboratories with 14.76%, Medtronic with 7.85%, LivaNova PLC with 3.32%, Terumo Corporation with 2.85%, Berlin Heart GmbH with 1.46%, Cirtec with 1.37%, Jarvik Heart Inc. with 0.86%, SynCardia Systems, LLC. with 0.80% and Calon Cardio-Technology Ltd with 0.33%.

The top opportunities in the ventricular assist device market segmented by product will arise in the left ventricular assist devices (LVADs) segment, which will gain $1,106.5 million of global annual sales by 2027. The top opportunities in the ventricular assist device market segmented by type will arise in the continuous flow segment, which will gain $1,157.8 million of global annual sales by 2027. The top opportunities in segment by design will arise in the implantable ventricular assist devices segment, which will gain $1,026.7 million of global annual sales by 2027. The top opportunities in segment by application will arise in the destination therapy segment, which will gain $587.0 million of global annual sales by 2027. The top opportunities in segment by end user will arise in the hospitals segment, which will gain $931.0 million of global annual sales by 2027. The ventricular assist device market size will gain the most in the USA at $1,053.1 million.

Market-trend-based strategies for the ventricular assist device market include focus on lengthening effective life of VADs, miniaturization of VADs, advanced pump technologies, increased focus on VAD safety and effectiveness, focus on reduction in side effects of VADs and percutaneously inserted ventricular assist devices.

Player-adopted strategies in the ventricular assist device market include focus on enhancing business operations through receiving regulatory approvals, focus on providing innovative solutions and focus on making life-saving technology more accessible to critically ill patients.

To take advantage of the opportunities, The Business Research Company recommends the ventricular assist device companies to focus on advanced pump technologies, invest in percutaneously inserted ventricular assist devices, focus on VAD safety and effectiveness, expand in emerging markets, continue to focus on developed markets, focus on partnerships and collaborations, provide competitively priced offerings, participate in trade shows and events, focus on aging population and continue to target fast-growing end-users.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（二次医療）の最新刊レポート

The Business Research Company　(TBRC) 社の最新刊レポート

本レポートと同じKEY WORD（ambulatory surgical）の最新刊レポート

よくあるご質問

The Business Research Company　(TBRC)社はどのような調査会社ですか?

The Business Research Company (TBRC)はインドを主要拠点に世界の多様な市場を調査・予測し、調査レポートを積極的に出版しています。調査対象には技術、ライフサイエンス、重... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（二次医療）の最新刊レポート

The Business Research Company (TBRC) 社の最新刊レポート

本レポートと同じKEY WORD（ambulatory surgical）の最新刊レポート

よくあるご質問

The Business Research Company (TBRC)社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?

The Business Research Company　(TBRC) 社の最新刊レポート

The Business Research Company　(TBRC)社はどのような調査会社ですか?